MarketScreener Homepage > Equities > Nasdaq > Moderna, Inc. MRNA

Report

Real-time Estimate BATS EXCHANGE - 03/01 04:31:06 pm
147.8150	USD		-4.52%

10:20a

GLOBAL MARKETS LIVE: Berkshire Hathaway, Johnson & Johnson, AstraZeneca…

10:05a

J&J CEO sees COVID-19 shots in American arms in 1-2 days as shipping starts

08:08a

JOHNSON & JOHNSON : J&J Covid-19 Vaccine to Start Arriving as Soon as Tuesday, U.S. Administration Says

Summary

Quotes 5-day view Delayed Quote.

Delayed Nasdaq

02/23/2021	02/24/2021	02/25/2021	02/26/2021	03/01/2021	Date
150.17(c)	144.79(c)	148.38(c)	154.81(c)	147.35	Last
15 509 168	9 757 204	15 172 131	13 445 239	4 222 947	Volume
-5.77%	-3.58%	+2.48%	+4.33%	-4.82%	Change

More quotes

Financials (USD)

Sales 2021	16 474 M - -
Net income 2021	8 798 M - -
Net cash position 2021	13 038 M - -
P/E ratio 2021	7,12x
Yield 2021	-

Sales 2022	13 137 M - -
Net income 2022	5 654 M - -
Net cash position 2022	18 931 M - -
P/E ratio 2022	11,2x
Yield 2022	-

Capitalization	61 888 M 61 888 M -
EV / Sales 2021	2,97x
EV / Sales 2022	3,27x
Nbr of Employees	1 300
Free-Float	90,0%

More Financials

Company

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for infectious, autoimmune and cardiovascular diseases. Turnover per type of income can be broken down as follows: - Collaboration revenue (79.8%); - Grant revenue (20.2%). At the end of 2019, the group possessed a portfolio of 6 development candidates in clinical studies, with three in phase II and...

Sector

Biotechnology & Medical Research

Calendar

03/01 | 08:00am

Presentation

More about the company

Notations Surperformance© of Moderna, Inc.

Trading Rating :

Investor Rating :

More Ratings

All news about MODERNA, INC.

10:20a	GLOBAL MARKETS LIVE: Berkshire Hathaway, Johnson & Johnson, AstraZeneca…
10:05a	J&J CEO sees COVID-19 shots in American arms in 1-2 days as shipping starts	RE
08:08a	JOHNSON & JOHNSON : J&J Covid-19 Vaccine to Start Arriving as Soon as Tuesday, ..	DJ
08:01a	Flowserve supplying pumps, valves for Pfizer vaccine production	RE
07:41a	Hungary stretches vaccine supply to counter "exponential" rise in cases	RE
07:30a	ASTRAZENECA : sold out of vaccine maker Moderna last year	RE
07:25a	MODERNA : Chardan Adjusts Moderna's Price Target to $182 From $107, Keeps Buy R..	MT
04:49a	ASTRAZENECA : Sells Stake in Moderna for More Than $1 Billion -The Times of Lon..	DJ
04:43a	Homebuilders, miners push British stocks higher	RE
03:26a	MODERNA : Orban chooses to receive Chinese jab to boost trust in non-EU vaccine..	AQ
02/28	MARKET CHATTER : AstraZeneca Sells Moderna Stake for $1.2 Billion	MT
02/28	NEWS HIGHLIGHTS : Top Company News of the Day	DJ
02/28	Johnson & Johnson's Covid-19 Vaccine Gets Green Light From CDC -- 3rd Update	DJ
02/28	JOHNSON & JOHNSON : CDC Director Signs Recommendation for J&J Covid-19 Vaccine ..	DJ
02/28	JOHNSON & JOHNSON : U.S. Vaccine Panel Recommends J&J Covid-19 Vaccine for Adul..	DJ

More news

News in other languages on MODERNA, INC.

10:46a	CORONA-ENTSCHEIDUNGEN : Habeck warnt vor vorschnellen Lockerungen
10:01a	EU-Kommissarin fordert mehr Tempo beim Corona-Impfen
09:21a	Les valeurs à suivre aujourd'hui à Wall Street Lundi 1er mars 2021
08:50a	MODERNA : AstraZeneca a vendu sa participation en 2020
08:15a	ASTRAZENECA : vendió su participación en Moderna el año pasado

More news

Analyst Recommendations on MODERNA, INC.

07:25a	MODERNA : Chardan Adjusts Moderna's Price Target to $182 From $107, Keeps Buy R..	MT
02/26	MODERNA : JP Morgan Adjusts Moderna's Price Target to $121 From $89, Maintains ..	MT
02/26	MODERNA : Goldman Sachs Adjusts Moderna's Price Target to $207 From $171, Maint..	MT

More recommendations

Stock Trading Strategies

	MODERNA, INC. - 2020
The beginning of the move

BUY

More Stock Trading Analysis

Provided by Scoopnest.com

Analysis

Wall Street ends sharply lower, tech selloff weighs as bond yields climb